Gemphire Therapeutics Blog | Talkmarkets | Page 1
No data available
No data available

People who follow this stock (18)

Latest Posts

About This Stock More About This Stock
On The Fly: Top Stock Stories For Friday, June 29, 2018
Article By: The Fly
Friday, June 29, 2018 11:49 PM EST
Stocks opened in positive territory after taking their cue from European and Asian markets, which traded higher overnight. Here is a brief roundup of notable economic events, company news and the major movers of the week.
In this article: DB, GS, MS, NKE, CVG, SNX, GM, STZ, THC, CELG, XLRN, GEMP
Read
Gemphire Announces Pricing Of $22 Million Public Offering Of Common Stock
Article By: NASDAQ GlobeNewswire
Thursday, February 8, 2018 12:42 PM EST
Gemphire Therapeutics Inc. today announced the pricing of its previously announced underwritten public offering of 3,142,858 shares of its common stock at a public offering price of $7.00 per share.
In this article: GEMP
Read
3 Market-Beating Stocks For Your 2018 Radar (With Extreme Upside Potential)
Article By: TipRanks
Monday, October 16, 2017 8:47 AM EST
This little-known biotech stock has only received three buy ratings from top analysts in the last three months. However, these three analysts are all confident on one thing: that Gemphire has serious upside potential.
In this article: MCRB, LITE, GEMP
Read
Gemphire's Early-Stage Status Keeps Us Very Cautious On The IPO
Article By: Don Dion
Wednesday, June 22, 2016 11:54 AM EST
Gemphire Therapeutics Inc. filed its S-1A on June 13 in advance of its June 23 IPO. GEMP hopes to raise $56.062 million in its IPO with a price range of $11 to $13 per share for its 3.75 million shares and overallotment.
In this article: GEMP
Read

Latest Tweets for $GEMP

No tweets yet!